Covered recipient · General Payments record
KARTHI SUBBANNAN
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$7,796.10
- Reported across 88 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,480.84 | 65 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $175.58 | 10 |
| Celgene Corporation | $121.03 | 4 |
| GlaxoSmithKline, LLC. | $108.47 | 4 |
| Merck Sharp & Dohme Corporation | $97.73 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $89.13 | 3 |
| Acerta Pharma LLC | $66.34 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $60.09 | 3 |
| Regeneron Healthcare Solutions, Inc. | $59.84 | 2 |
| Daiichi Sankyo Inc. | $59.44 | 3 |
| E.R. Squibb & Sons, L.L.C. | $52.76 | 3 |
| Lilly USA, LLC | $51.43 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $49.72 | 2 |
| Gilead Sciences, Inc. | $49.13 | 2 |
| Alexion Pharmaceuticals, Inc. | $45.01 | 2 |
| Tempus AI, Inc | $44.35 | 1 |
| ABBVIE INC. | $42.27 | 2 |
| EISAI INC. | $31.98 | 1 |
| TerSera Therapeutics LLC | $31.92 | 1 |
| ARRAY BIOPHARMA INC | $29.25 | 3 |
| Karyopharm Therapeutics Inc. | $28.27 | 1 |
| BeiGene USA, Inc. | $25.55 | 1 |
| Janssen Biotech, Inc. | $22.07 | 1 |
| SpringWorks Therapeutics, Inc. | $21.76 | 1 |
| Incyte Corporation | $21.27 | 1 |
| Mirati Therapeutics, Inc. | $20.27 | 1 |
| Pharmacosmos Therapeutics Inc. | $20.04 | 1 |
| Acrotech Biopharma Inc. | $19.81 | 1 |
| Genentech USA, Inc. | $18.38 | 1 |
| Deciphera Pharmaceuticals Inc. | $17.95 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (65)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.